Service notifications for recommended Technology Appraisals (TAs)
Technology Appraisals are listed below in alphanumerical order with links to further information on the NICE website.
| Title | Description | Date added | Download |
|---|---|---|---|
| NICE TA1127 | Service Notification Nivolumab with chemotherapy for neoadjuvant treatment then alone for adjuvant treatment of resectable non-small-cell lung cancer | 13-05-2026 | DownloadPreview |
| NICE TA1139 | Service Notification Epcoritamab for treating relapsed or refractory follicular lymphoma after 2 or more lines of systemic treatment | 13-05-2026 | DownloadPreview |
| NICE TA1133 | Service Notification Belantamab mafodotin with pomalidomide and dexamethasone for previously treated multiple myeloma | 13-05-2026 | DownloadPreview |
| NICE TA1136 (review of TA212 and partial review of TA118 & TA242) | Service Notification Bevacizumab (originator and biosimilars) with fluoropyrimidine-based chemotherapy (review of TA212 and partial review of TA118 & TA242) | 13-05-2026 | DownloadPreview |
| NICE TA1138 | Service Notification Durvalumab with gemcitabine and cisplatin for neoadjuvant treatment then alone for adjuvant treatment of muscle-invasive bladder cancer | 13-05-2026 | DownloadPreview |
| NICE TA1128 (review of TA937) | Service Notification Targeted-release budesonide for treating primary IgA nephropathy (review of TA937) | 13-05-2026 | DownloadPreview |
| NICE TA1129 (review of TA673) | Service Notification Niraparib for maintenance treatment of advanced ovarian, fallopian tube and peritoneal cancer (review of TA673) | 13-05-2026 | DownloadPreview |
| NICE TA1130 | Service Notification Talazoparib with enzalutamide for untreated hormone-relapsed metastatic prostate cancer | 13-05-2026 | DownloadPreview |
| NICE TA1127 | Service Notification Nivolumab with chemotherapy for neoadjuvant treatment then alone for adjuvant treatment of resectable non-small-cell lung cancer (1) | 13-05-2026 | DownloadPreview |
| NICE TA1120 (review of TA645) | Service Notification Avelumab with axitinib for untreated advanced renal cell carcinoma | 29-04-2026 | DownloadPreview |
| NICE TA1056 | Service Notification Molnupiravir for treating COVID-19 (update) | 29-04-2026 | DownloadPreview |
| NICE TA1122 | Service Notification Amivantamab with lazertinib for untreated EGFR mutation-positive advanced non-small-cell lung c | 29-04-2026 | DownloadPreview |
| NICE TA1119 (review of TA663) | Service Notification Venetoclax with obinutuzumab for untreated chronic lymphocytic leukaemia | 29-04-2026 | DownloadPreview |
| NICE TA878 | UPDATE Nirmatrelvir plus ritonavir and tocilizumab for treating COVID-19 | 29-04-2026 | DownloadPreview |
| NICE TA1134 (review of TA648) | Service Notification Dupilumab for treating severe chronic rhinosinusitis with nasal polyps | 29-04-2026 | DownloadPreview |
| NICE TA1131 | Service Notification Obinutuzumab with mycophenolate mofetil for treating lupus nephritis | 29-04-2026 | DownloadPreview |
| TA1121 | Service Notification Acoramidis for treating transthyretin amyloidosis with cardiomyopathy | 20-03-2026 | DownloadPreview |
| TA1107 | Service Notification Delgocitinib for treating moderate to severe chronic hand eczema | 09-03-2026 | DownloadPreview |
| TA1106 | Service Notification Cabotegravir for preventing HIV-1 in adults and young people | 04-03-2026 | DownloadPreview |
| TA1117 | Dostarlimab with platinum-containing chemotherapy for treating primary advanced or recurrent endometrial cancer with microsatellite stability or mismatch repair proficiency | 04-03-2026 | DownloadPreview |